Life360 (LIF) CFO Reports Share Sale and 79,317-Share Trust Transfer

Rhea-AI Filing Summary

Life360, Inc. (LIF) Form 4: This filing reports insider transactions by John Burke Russell, identified as the companys Chief Financial Officer. On 08/26/2025 the reporting person sold 16,287 shares of common stock at a weighted-average price of $90.42 per share (individual trade prices ranged from $90.07 to $90.72). After the sale, the filing shows 63,030 shares beneficially owned indirectly, held by the Russell John Burke Revocable Trust. The filing also notes a prior transfer of 79,317 directly held shares to that trust, which the filer states was exempt from Section 16 under Rule 16a-13. Additionally, 111,231 restricted stock units remain recorded as contingent rights to receive common stock upon vesting. The form is signed by Allison Chang, Attorney-in-Fact, dated 08/28/2025.

Positive

• Timely disclosure of insider sale and transfers via Form 4
• Detailed pricing provided (weighted-average $90.42 and price range $90.07–$90.72)
• Clear RSU disclosure showing 111,231 contingent units outstanding

Negative

• Insider sale of 16,287 shares by the CFO (reduces direct holdings)
• Direct-to-trust transfer of 79,317 shares reduces directly held shares

Insights

Securities Analyst

TL;DR: CFO sold a modest holding, transferred direct shares into a revocable trust, and holds significant unvested RSUs.

The sale of 16,287 shares at a weighted-average price of $90.42 is explicitly reported and the filing documents a prior transfer of 79,317 directly held shares into a revocable trust under Rule 16a-13 exemption. Post-transaction indirect beneficial ownership is 63,030 shares and 111,231 RSUs remain outstanding as contingent rights. These are standard Section 16 disclosures; the filing provides granular price range details and an undertaking to provide trade-level breakouts if requested.

Corporate Governance Expert

TL;DR: Transaction is routine insider disclosure showing sale and trust transfer; no regulatory noncompliance disclosed.

The Form 4 documents both a sale and an indirect ownership structure via a revocable trust, with the filer asserting the trust transfer was exempt under Rule 16a-13. The filing is signed by an attorney-in-fact and includes the explanatory note about weighted-average pricing and RSU counts. The report contains no statements of litigation, policy breaches, or omitted material facts within the filing text.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burke Russell John

(Last) (First) (Middle)

C/O LIFE360, INC.

1900 SOUTH NORFOLK STREET, SUITE 310

(Street)

SAN MATEO CA 94403

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Life360, Inc. [ LIF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/26/2025		S		16,287	D	$90.42(1)	63,030(2)	I	Held by the Russell John Burke Revocable Trust
Common stock								111,231(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $90.07 to $90.72, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

2. The Reporting Person transferred 79,317 directly held shares to the Russell John Burke Revocable Trust, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.

3. Reflects 111,231 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Remarks:

	/s/ Allison Chang, Attorney-in-Fact	08/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Life360 (LIF) disclose on this Form 4?

The CFO sold 16,287 shares on 08/26/2025 at a weighted-average price of $90.42 and transferred 79,317 directly held shares into a revocable trust.

How many shares does the reporting person beneficially own after the reported transactions?

The filing reports 63,030 shares beneficially owned indirectly after the transactions.

What price range were the shares sold at in the LIF Form 4?

The shares were sold in multiple transactions at prices ranging from $90.07 to $90.72 per share; weighted-average price $90.42.

Does the filing disclose any unvested equity awards for the reporting person?

Yes. The filing reflects 111,231 restricted stock units that represent contingent rights to receive common stock upon vesting.

Were the transfers to the revocable trust reported as exempt from Section 16 requirements?

Yes. The filer states the transfer of 79,317 directly held shares to the Russell John Burke Revocable Trust was exempt under Rule 16a-13.